Jeremie Calais, MD, of the University of California, Los Angeles, CA, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA and discusses the use of gallium-labelled PSMA-11 PET/CT imaging in the screening of prostate cancer and it’s greatly increased specificity compared to other screening technologies.
